CONMED Corporation

CNMD

US2074101013

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 16:00:02 2024-06-28 EDT			5-day change	1st Jan Change
69.32 ^USD	+2.70%		+3.31%	-36.70%

06-17	Conmed Insider Sold Shares Worth $287,280, According to a Recent SEC Filing	MT
05-22	CONMED Keeps Quarterly Dividend at $0.20 a Share, Payable July 5 to Shareholders of Record June 14	MT

Conmed Corporation Provides Sales Guidance for the Full Year 2019

January 22, 2019 at 04:01 pm

CONMED Corporation provided sales guidance for the full year 2019. The Company expects full-year 2019 constant-currency sales growth in the range of 5.0% to 6.0%.

Latest news about CONMED Corporation

Conmed Insider Sold Shares Worth $287,280, According to a Recent SEC Filing	06-17	MT
CONMED Keeps Quarterly Dividend at $0.20 a Share, Payable July 5 to Shareholders of Record June 14	05-22	MT
CONMED Corporation Declares Quarterly Cash Dividend, Payable on July 5, 2024	05-22	CI
Transcript : CONMED Corporation Presents at Bank of America Health Care Conference 2024, May-14-2024 02:20 PM	05-14
Wells Fargo Adjusts Price Target on CONMED to $77 From $98, Maintains Equalweight Rating	04-25	MT
Tranche Update on CONMED Corporation's Equity Buyback Plan announced on February 15, 2005.	04-25	CI
Needham Lowers Price Target on CONMED to $107 From $129, Notes Slight Guidance Cut Due to Currency, Keeps Buy Rating	04-25	MT
Transcript : CONMED Corporation, Q1 2024 Earnings Call, Apr 24, 2024	04-24
Earnings Flash (CNMD) CONMED CORPORATION Posts Q1 Revenue $312.3M, vs. Street Est of $306.7M	04-24	MT
CONMED Corporation Promotes Patrick Beyer to Chief Operating Officer	04-24	CI
CONMED Corporation Revises Earnings Guidance for the Full Year 2024	04-24	CI
CONMED Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	04-24	CI
CONMED Corporation Announces Not Stand for Re-Election of Jerome Lande as Director	04-08	CI
Tranche Update on CONMED Corporation's Equity Buyback Plan announced on February 15, 2005.	02-28	CI
CONMED Corporation Declares Quarterly Cash Dividend, Payable on April 5, 2024	02-27	CI
Sector Update: Health Care Stocks Rise in Late Afternoon	02-01	MT
CONMED Shares Fall After Q4 Results Trail Analyst Estimates	02-01	MT
Needham Adjusts Price Target on CONMED to $129 From $119, Maintains Buy Rating	02-01	MT
JPMorgan Cuts CONMED Price Target to $115 From $135, Maintains Overweight Rating	02-01	MT
CONMED Q4 Adjusted Earnings, Net Sales Rise; Sets 2024 Outlook; Shares Drop	01-31	MT
Transcript : CONMED Corporation, Q4 2023 Earnings Call, Jan 31, 2024	01-31
CONMED Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	01-31	CI
Earnings Flash (CNMD) CONMED CORPORATION Posts Q4 Revenue $327M, vs. Street Est of $332.2M	01-31	MT
CONMED Corporation Provides Financial Guidance for the Full Year 2024	01-31	CI
CONMED Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	01-31	CI

CONMED Corporation is a medical technology company, which provides surgical devices and equipment for minimally invasive procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine and lower extremities instrumentation and implants, small bone, large bone, and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures and fees related to the sales representation, promotion, and marketing of sports medicine allograft tissue. General surgery consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-07-23 - Q2 2024 Earnings Release (Projected)

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for CONMED Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

69.32 USD

Average target price

92.38 USD

Spread / Average Target

+33.26%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
CONMED CORPORATION	-36.70%	2.14B
ABBOTT LABORATORIES	-5.60%	181B
MEDTRONIC PLC	-4.45%	101B
BECTON, DICKINSON AND COMPANY	-4.15%	67.54B
DEXCOM, INC.	-8.63%	45.09B
CENCORA, INC.	+9.70%	44.37B
HOYA CORPORATION	+7.40%	40.7B
METTLER-TOLEDO INTERNATIONAL, INC.	+15.22%	29.85B
TERUMO CORPORATION	+13.31%	24.49B
WEST PHARMACEUTICAL SERVICES, INC.	-6.46%	23.99B

Other Medical Equipment, Supplies & Distribution